| Literature DB >> 29913238 |
Somaye Heidari Sharafdarkolaee1, Majid Motovali-Bashi2, Pooria Gill3.
Abstract
Beta-thalassemia (β-thalassemia) is a globally genetic diseases, and is most prevalent in the Middle East, particularly in Iran. Carrier detection and prenatal diagnosis are the best ways to managing it, and to prevent new community cases from emerging. We report on a simple method for rapid detection of the worst β-thalassemia point mutation in Iran (IVS-II-1 G>A), using a nano-based ligation assay, this was performed using probes with labeled magnetic nanoparticles and quantum dots. After optimizing the technique, 50 DNA samples were genotyped with this method. We found a frequency of 72% for IVSII-1 (G˃A) mutation (42% heterozygote, and 30% mutant homozygote) with a highly sensitive nano-based ligation genotyping system, offering excellent sensitivity and specificity for point mutation detection; it has been demonstrated to be inaccurate, sensitive, cost-effective, and rapid technique for single nucleotide polymorphism (SNP) genotyping. Published by Elsevier B.V.Entities:
Keywords: Beta globin; Beta-thalassemia; IVSII-1 (G>A); Nano-based ligation assay
Mesh:
Substances:
Year: 2018 PMID: 29913238 DOI: 10.1016/j.gene.2018.06.009
Source DB: PubMed Journal: Gene ISSN: 0378-1119 Impact factor: 3.688